Table of Contents Table of Contents
Previous Page  567 692 Next Page
Information
Show Menu
Previous Page 567 692 Next Page
Page Background no suspected adenopathy before or during surgery? BJU Int 2001;88:169–72

.

[21]

Bekema HJ, MacLennan S, Imamura M, et al. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol 2013;64:799–810.

[22]

Feuerstein MA, Kent M, Bazzi WM, Bernstein M, Russo P. Analysis of lymph node dissection in patients with 7-cm renal tumors. World J Urol 2014;32:1531–6.

[23]

Feuerstein MA, Kent M, Bernstein M, Russo P. Lymph node dissec- tion during cytoreductive nephrectomy: a retrospective analysis. Int J Urol 2014;21:874–9

.

[24]

Sun M, Trinh QD, Bianchi M, et al. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data. BJU Int 2014;113:36–42

.

[25]

Karmali RJ, Suami H, Wood CG, Karam JA. Lymphatic drainage in renal cell carcinoma: back to the basics. BJU Int 2014;114:806–17

.

[26]

Hutterer GC, Patard JJ, Perrotte P, et al. Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer 2007;121:2556–61

.

[27]

Giuliani L, Giberti C, Martorana G, Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 1990;143:468–73.

[28]

Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol 2008;180:99–103.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 5 6 0 – 5 6 7

567